The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global veterinary molecular diagnostics market was valued at US$ 581.4 Million in 2021.
We expect the global veterinary molecular diagnostics market to exhibit a CAGR of 9.40% during
The widespread utilization of veterinary molecular diagnostics in veterinary health centers and
research laboratories to facilitate fast and specific diagnosis of animal diseases, is primarily driving
the global veterinary molecular diagnostics market.
The sudden outbreak of the COVID-19 pandemic has led to the growing adoption of veterinary
molecular diagnostics owing to the rising need for Polymerase Chain Reaction (PCR) testing to
analyze the effect of the COVID-19 infection in animals.
Based on the product, the global veterinary molecular diagnostics market has been divided into kits
and reagents, instruments, and software and services. Among these, kits and reagents exhibit a clear
dominance in the market.
Based on the technology, the global veterinary molecular diagnostics market can be categorized into
real time PCR, microarray, and DNA sequencing. Currently, real time PCR technology holds the
majority of the global market share.
Based on the animal type, the global veterinary molecular diagnostics market has been segmented
into companion animal and livestock animal, where companion animal represents the largest market
Based on the disease type, the global veterinary molecular diagnostics market can be bifurcated into
vector-borne diseases, respiratory pathogens, diarrhea pathogens, and others. Among these, vector-
borne diseases account for the majority of the total market share.
On a regional level, the market has been classified into North America, Europe, Asia Pacific, Middle
East and Africa, and Latin America, where North America currently dominates the global market.
Some of the major players in the global veterinary molecular diagnostics market include Biochek
B.V., bioMérieux SA, HealthGene Corporation, Heska Corporation, IDEXX Laboratories Inc., INDICAL
BIOSCIENCE GmbH, Ingenetix GmbH, NEOGEN Corporation, Qiagen N.V, Thermo Fisher Scientific
Inc., Veterinary Molecular Diagnostics Inc., and Zoetis Inc.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at